Format
Items per page
Sort by

Send to:

Choose Destination

Results: 18

Related Articles by Review for PubMed (Select 21269454)

1.

Detection of silent myocardial ischemia in asymptomatic patients with diabetes: results of a randomized trial and meta-analysis assessing the effectiveness of systematic screening.

Lièvre MM, Moulin P, Thivolet C, Rodier M, Rigalleau V, Penfornis A, Pradignac A, Ovize M; DYNAMIT investigators.

Trials. 2011 Jan 26;12:23. doi: 10.1186/1745-6215-12-23.

2.

Silent myocardial ischemia screening in patients with diabetes mellitus.

Barthelemy O, Le Feuvre C, Timsit J.

Arq Bras Endocrinol Metabol. 2007 Mar;51(2):285-93. Review.

3.

[Silent myocardial ischemia in diabetic patients: to screen or not to screen?].

Meyer P.

Rev Med Suisse. 2005 Jun 1;1(22):1505-7, 1509-10. Review. French.

PMID:
16025890
4.

Prevention of diabetes and reduction in major cardiovascular events in studies of subjects with prediabetes: meta-analysis of randomised controlled clinical trials.

Hopper I, Billah B, Skiba M, Krum H.

Eur J Cardiovasc Prev Rehabil. 2011 Dec;18(6):813-23. doi: 10.1177/1741826711421687. Epub 2011 Aug 30. Review.

PMID:
21878448
5.

Systematic review on urine albumin testing for early detection of diabetic complications.

Newman DJ, Mattock MB, Dawnay AB, Kerry S, McGuire A, Yaqoob M, Hitman GA, Hawke C.

Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163. Review.

6.

Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials.

Boussageon R, Bejan-Angoulvant T, Saadatian-Elahi M, Lafont S, Bergeonneau C, Kassaï B, Erpeldinger S, Wright JM, Gueyffier F, Cornu C.

BMJ. 2011 Jul 26;343:d4169. doi: 10.1136/bmj.d4169. Review.

7.

Myocardial ischemia: a silent epidemic in Type 2 diabetes patients.

Le Feuvre C, Jacqueminet S, Barthelemy O.

Future Cardiol. 2011 Mar;7(2):183-90. doi: 10.2217/fca.10.127. Review.

PMID:
21453025
8.

Managing the asymptomatic diabetic patient with silent myocardial ischaemia.

Doubell AF.

Cardiovasc J S Afr. 2002 Jul-Aug;13(4):189-93. Review.

9.

Coronary artery calcium score prediction of all cause mortality and cardiovascular events in people with type 2 diabetes: systematic review and meta-analysis.

Kramer CK, Zinman B, Gross JL, Canani LH, Rodrigues TC, Azevedo MJ, Retnakaran R.

BMJ. 2013 Mar 25;346:f1654. doi: 10.1136/bmj.f1654. Review.

10.

Sulphonylureas and risk of cardiovascular disease: systematic review and meta-analysis.

Phung OJ, Schwartzman E, Allen RW, Engel SS, Rajpathak SN.

Diabet Med. 2013 Oct;30(10):1160-71. doi: 10.1111/dme.12232. Review.

PMID:
23663156
11.

Coronary artery calcium and cardiovascular risk in diabetes.

Elkeles RS.

Atherosclerosis. 2010 Jun;210(2):331-6. doi: 10.1016/j.atherosclerosis.2009.11.026. Epub 2009 Nov 24. Review.

PMID:
19969300
12.

Why to screen heart disease in diabetes.

Fadini GP, de Kreutzenberg SV, Tiengo A, Avogaro A.

Atherosclerosis. 2009 May;204(1):11-5. doi: 10.1016/j.atherosclerosis.2008.08.044. Epub 2008 Sep 27. Review.

PMID:
18977481
13.

Asymptomatic coronary artery disease in type II diabetes.

Baweja PS, Sandesara PB, Ashraf MJ.

Mo Med. 2014 Jan-Feb;111(1):73-9. Review.

PMID:
24645303
14.

Subclinical cardiovascular disease assessment in persons with diabetes.

Warraich HJ, Nasir K.

Curr Cardiol Rep. 2013 May;15(5):358. doi: 10.1007/s11886-013-0358-2. Review.

PMID:
23529290
15.

Is there excess mortality in women screened with mammography: a meta-analysis of non-breast cancer mortality.

Erpeldinger S, Fayolle L, Boussageon R, Flori M, Lainé X, Moreau A, Gueyffier F.

Trials. 2013 Nov 5;14:368. doi: 10.1186/1745-6215-14-368. Review.

16.

A systematic review of predictive risk models for diabetes complications based on large scale clinical studies.

Lagani V, Koumakis L, Chiarugi F, Lakasing E, Tsamardinos I.

J Diabetes Complications. 2013 Jul-Aug;27(4):407-13. doi: 10.1016/j.jdiacomp.2012.11.003. Epub 2012 Dec 27. Review.

PMID:
23273850
17.

Diabetes and cancer I: risk, survival, and implications for screening.

Onitilo AA, Engel JM, Glurich I, Stankowski RV, Williams GM, Doi SA.

Cancer Causes Control. 2012 Jun;23(6):967-81. doi: 10.1007/s10552-012-9972-3. Epub 2012 May 3. Review.

18.

[Adiposity paradox in cardiovascular disease].

Holzgreve H.

MMW Fortschr Med. 2014 May 15;156(9):63-4. Review. German. No abstract available.

PMID:
24908893
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk